NCT06978114 2025-07-02A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract CancerSichuan Baili Pharmaceutical Co., Ltd.Phase 2 Recruiting46 enrolled
NCT06708858 2024-11-27Phase â…¡ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract CancerChinese PLA General HospitalPhase 2 Recruiting35 enrolled